Publication | Closed Access
Design and biological evaluation of 99mTc-N2S2-Tat(49–57)-c(RGDyK): A hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins
12
Citations
14
References
2013
Year
Tumor BiologyOncologyEngineeringMedicineRadionuclide TherapyTheranosticsRadiopharmaceutical TherapyBiological EvaluationTumor TargetingPharmacologyRadiation OncologyNuclear MedicineCancer ResearchBiomolecular EngineeringHybrid Radiopharmaceutical
| Year | Citations | |
|---|---|---|
Page 1
Page 1